Atara Biotherapeutics Inc
ATRA
Market Cap$54.09M
Close$
$-2.33
128.2% downside
Current Fair Value
128.2% downsideOvervalued by 128.2% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $54.09 Million |
|---|---|
| Enterprise Value | $84.33 Million |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-11.41 |
| Beta | 0.18 |
| Outstanding Shares | 10,764,000 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -5.48 |
|---|---|
| PEG | 2.49 |
| Price to Sales | 0.92 |
| Price to Book Ratio | -1.38 |
| Enterprise Value to Revenue | 0.83 |
| Enterprise Value to EBIT | -6.73 |
| Enterprise Value to Net Income | -6 |
| Total Debt to Enterprise | 0.52 |
| Debt to Equity | -0.8 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Atara Biotherapeutics Inc
CEO: Pascal Touchon